OOIR: Observatory of International Research

Papers

(The median citation count of Cellular & Molecular Immunology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
MicroRNAs in mesenchymal stem cells: the key to decoding systemic lupus erythematosus	854
Comment to: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia	472
Autophagy takes the STING out of DNA sensing	353
ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC	348
MHC class II in renal tubules plays an essential role in renal fibrosis	283
From blood to tissue: take a deeper look at B cells in lupus	238
Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA	234
Identification and characterization of a monoclonal antibody blocking the SARS-CoV-2 spike protein–ACE2 interaction	185
Aberrant cytokine milieu and signaling affect immune cell phenotypes and functions in tuberculosis pathology: What can we learn from this phenomenon for application to inflammatory syndromes?	157
PKM2 controls the degranulation of secondary and tertiary granules in neutrophils by phosphorylating SNAP-23	155
CD81, a new actor in the development of preeclampsia	143
ACE2 expression is regulated by AhR in SARS-CoV-2-infected macaques	142
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection	140
Factors affecting the migration of ILC2s in allergic disease	106
SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients	102
Kupffer cell restoration after partial hepatectomy is mainly driven by local cell proliferation in IL-6-dependent autocrine and paracrine manners	100
Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity	98
Neuron navigator 2 is a novel mediator of rheumatoid arthritis	97
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron	96
Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases	96
Dendritic cells in cancer immunology	92
Microenvironmental influences on T cell immunity in cancer and inflammation	90
Metabolism of tissue macrophages in homeostasis and pathology	89
Impact of intracellular innate immune receptors on immunometabolism	86
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids	77

Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins	74
An update on the regulatory mechanisms of NLRP3 inflammasome activation	73
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals	73
Exploring innate immunity in cancer immunotherapy: opportunities and challenges	72
Activation or exhaustion of CD8+ T cells in patients with COVID-19	70
Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy	68
Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice	65
Neutrophils in chronic inflammatory diseases	65
Thymic iNKT cell differentiation at single-cell resolution	63
Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains	62
MicroRNA-99a: a potential double-edged sword targeting macrophage inflammation and metabolism	55
Mucins produced by type II pneumocyte: culprits in SARS-CoV-2 pathogenesis	54
Advances and challenges of mesenchymal stem cells for pregnancy-related diseases	54
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency	52
CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis	49
No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1	48
The membrane-associated E3 ubiquitin ligase MARCH3 downregulates the IL-6 receptor and suppresses colitis-associated carcinogenesis	47
Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention	47
A new perspective is needed for positive selection of germinal center B cells with higher-affinity B cell receptors	46
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination	44
Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes	43
Remote hyperinflammation drives neurological disease via T-cell-mediated innate-like cytotoxicity	43
Biology and pathology of the uterine microenvironment and its natural killer cells	42
STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis	41
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors	40
Inflammatory processes in the liver: divergent roles in homeostasis and pathology	39
sTREM-1 is a specific biomarker of TREM-1 pathway activation	39
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy	38
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model	38
Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters	37
Autophagy receptor CCDC50 tunes the STING-mediated interferon response in viral infections and autoimmune diseases	37
Diet, lipids, and antitumor immunity	36
The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling	35
Supplying the trip to antibody production—nutrients, signaling, and the programming of cellular metabolism in the mature B lineage	32
Reversing the mitochondrial stress-induced exhaustion of CD8+ T cells for improving cancer immunotherapy	32
Neutralizing antibodies for the prevention and treatment of COVID-19	32
Protein synthesis, degradation, and energy metabolism in T cell immunity	32
Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells	31
Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2	31
New insights into follicular helper T cell response and regulation in autoimmune pathogenesis	30
Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo	29
Macrophage Dicer promotes tolerogenic apoptotic cell clearance and immune tolerance by inhibiting pentose phosphate pathway activity	27
New aspects of HSC mobilization for better therapeutic outcomes	26
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia	25
Publisher Correction: Epitopes for a 2019-nCoV vaccine	25
CAR-T cell therapy: new hope for systemic lupus erythematosus patients	24
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells	22
Ripping the Ripoptosome: a novel path for blocking allergic inflammation?	22
Meteorin-β/Meteorin like/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma	22
HIV-1 Vif suppresses antiviral immunity by targeting STING	21

T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant	21
IL-33 in COVID-19: friend or foe?	21
A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors	21
Metabolic programming in dendritic cells tailors immune responses and homeostasis	20
Systems-based approaches to study immunometabolism	19
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies	19